Vancouver, BC – Kardium Inc., an emerging leader in advanced solutions for atrial fibrillation, is proud to announce the publication of the PULSAR clinical trial results in the Journal of the American College of… Read More
The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systems LE PONT-DE-CLAIX, France and BURGDORF, Switzerland, – BD (Becton, Dickinson and Company), a leading global medical… Read More
Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect Biosystems. Aspect will lead development, manufacturing and commercialisation, and Novo Nordisk will have defined rights to expand its… Read More
FRANKLIN LAKES, NJ – BD, a leading global medical technology company, will present its latest drug delivery innovations at Pharmapack 2026, Europe’s leading drug delivery event, taking place January 21–22,… Read More
CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled data from two Phase 3 studies. 65%… Read More
